ADGM (Adagio Medical Holdings, Inc.) Stock Financials & Earnings

ADGMAdagio Medical Holdings, Inc.

Mkt Cap$15M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)-$143,000

Net Income (TTM)-$75M

EPS (TTM)-$5.06

Free Cash Flow (TTM)-$24M

Gross Margin746.9%

Op. Margin47985.5%

Net Margin52154.8%

FCF Margin16471.3%

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-126.3%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	-$291K	-$6M
Q1 23	$60K	-$258K	-$7M
Q2 23	$121K	-$280K	-$7M
Q3 23	$41K	-$212K	-$9M
Q4 23	$78K	-$256K	-$5M
Q1 24	$26K	-$516K	-$9M
Q2 24	$254K	-$428K	-$7M
Q3 24	$185K	-$386K	-$11M
Q4 24	-$143K	-$442K	-$51M
Q1 25	$0	-$253K	-$7M
Q2 25	$0	-$342K	-$5M
Q3 25	$0	-$31K	-$6M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q4 22	$4M	—	—	$1M
Q1 23	$5M	—	—	$2M
Q2 23	$4M	—	—	—
Q3 23	$4M	—	—	$4M
Q4 23	$2M	—	—	$3M
Q1 24	$3M	—	—	$5M
Q2 24	$3M	—	—	—
Q3 24	$2M	—	—	$8M
Q4 24	$3M	$612K	$2M	—
Q1 25	$4M	—	—	—
Q2 25	$2M	—	—	—
Q3 25	$3M	—	—	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$6M	$0	$6M
Q1 23	$60K	$0	$60K
Q2 23	$18K	$0	$18K
Q3 23	$2M	$0	$2M
Q4 23	$1M	$0	$1M
Q1 24	$4M	$0	$4M
Q2 24	$2M	$0	$2M
Q3 24	$28M	$0	$28M
Q4 24	$21M	$0	$21M
Q1 25	$13M	$0	$13M
Q2 25	$8M	$0	$8M
Q3 25	$5M	$0	$5M

Shares Outstanding

Revenue Per Employee

Revenue / Employee